Literature DB >> 11702580

[Hypocretin (orexin) deficiency in narcolepsy-cataplexy].

S Nevsímalová1, J Vanková, K Sonka, J Faraco, W Rogers, S Overeem, E Mignot.   

Abstract

A mutation in the HCRT locus was proved in 18-yrs old male suffering from narcolepsy-cataplexy. He has demonstrated cataplectic attacks (brief spells of head dropping provoked by laughter) as well as imperative sleep in spells of several minutes up to one hour since the age of six months. He has suffered from severe bulimia since five years; later hypnagogic hallucinations, sleep paralysis and unquiet nocturnal sleep accompanied by periodic limb movements appeared. Symptoms are partially controlled with methylphenidate and either imipramine, clomipramine or fluoxetine. Periodic leg movements poorly responded to L-DOPA and clonazepam treatment. He is HLA-DQB1*0602 negative. Repeated MSLT (over 16 years followed-up period) showed extremely short latency with predominant SOREMPs and also nocturnal PSG recordings revealed fragmented sleep with SOREMPs. This case report demonstrates that hypocretin (orexin) mutations in human can produce the full narcolepsy phenotype and validates data recently reported in dog and mouse models suggesting a role for hypocretin (orexin) in the pathophysiology of narcolepsy and the regulation of REM sleep.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11702580

Source DB:  PubMed          Journal:  Sb Lek        ISSN: 0036-5327


  2 in total

Review 1.  Obstructive sleep apnea syndrome in Prader-Willi Syndrome: an unrecognized and untreated cause of cognitive and behavioral deficits?

Authors:  Danny Camfferman; Kurt Lushington; Fergal O'Donoghue; R Doug McEvoy
Journal:  Neuropsychol Rev       Date:  2006-09       Impact factor: 7.444

Review 2.  History of narcolepsy at Stanford University.

Authors:  Emmanuel J M Mignot
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.